Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v2.4.0.6
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)
Total
Cash
Professional Services
Licensed Technology
Common Stock
Common Stock
Cash
Common Stock
Professional Services
Common Stock
Licensed Technology
Additional Paid-in Capital
Additional Paid-in Capital
Cash
Additional Paid-in Capital
Professional Services
Additional Paid-in Capital
Licensed Technology
Deficit Accumulated During the Development Stage
BEGINNING BALANCE at Nov. 07, 2002                          
Issuance of common stock (in shares)           6,440,123 101,220            
Issuance of common stock   $ 590,269 $ 9,108     $ 64 $ 1     $ 590,205 $ 9,107    
ENDING BALANCE at Dec. 31, 2002 599,377       65       599,312        
ENDING BALANCE (in shares) at Dec. 31, 2002         6,541,343                
Issuance of common stock (in shares)           37,958   203,483          
Issuance of common stock   4,937   80,412       2   4,937   80,410  
Net loss (295,790)                       (295,790)
ENDING BALANCE at Dec. 31, 2003 388,936       67       684,659       (295,790)
ENDING BALANCE (in shares) at Dec. 31, 2003         6,782,784                
Net loss (342,761)                       (342,761)
ENDING BALANCE at Dec. 31, 2004 46,175       67       684,659       (638,551)
ENDING BALANCE (in shares) at Dec. 31, 2004         6,782,784                
Issuance of common stock (in shares)           610,664              
Issuance of common stock   835,868       6       835,862      
Net loss (481,837)                       (481,837)
ENDING BALANCE at Dec. 31, 2005 400,206       73       1,520,521       (1,120,388)
ENDING BALANCE (in shares) at Dec. 31, 2005         7,393,448                
Issuance of common stock (in shares)           2,202,179              
Issuance of common stock   7,097,072       22       7,097,050      
Common stock repurchased (in shares)         (43,819)                
Common stock repurchased (31,667)               (31,667)        
Stock-based compensation 43,994               43,994        
Net loss (963,440)                       (963,440)
ENDING BALANCE at Dec. 31, 2006 6,546,165       95       8,629,898       (2,083,828)
ENDING BALANCE (in shares) at Dec. 31, 2006         9,551,808                
Issuance of common stock (in shares)           60,250              
Issuance of common stock   250,000       1       249,999      
Exercise of warrant to purchase common stock (in shares)         75,045                
Exercise of warrant to purchase common stock 250,000       1       249,999        
Stock-based compensation 570,392               570,392        
Net loss (5,090,325)                       (5,090,325)
ENDING BALANCE at Dec. 31, 2007 2,526,232       97       9,700,288       (7,174,153)
ENDING BALANCE (in shares) at Dec. 31, 2007         9,687,103                
Issuance of common stock (in shares)           3,132,999              
Issuance of common stock   12,931,562       31       12,931,531      
Stock-based compensation 477,488               477,488        
Net loss (6,090,715)                       (6,090,715)
ENDING BALANCE at Dec. 31, 2008 9,844,567       128       23,109,307       (13,264,868)
ENDING BALANCE (in shares) at Dec. 31, 2008         12,820,102                
Stock-based compensation 502,199               502,199        
Net loss (6,219,873)                       (6,219,873)
ENDING BALANCE at Dec. 31, 2009 4,126,893       128       23,611,506       (19,484,741)
ENDING BALANCE (in shares) at Dec. 31, 2009         12,820,102                
Intrinsic value of beneficial conversion feature associated convertible debt 213,792               213,792        
Stock-based compensation 353,340               353,340        
Net loss (4,560,263)                       (4,560,263)
ENDING BALANCE at Dec. 31, 2010 133,762       128       24,178,638       (24,045,004)
ENDING BALANCE (in shares) at Dec. 31, 2010         12,820,102                
Issuance of common stock upon conversion of convertible notes (in shares)         4,181,535                
Issuance of common stock upon conversion of convertible notes 3,184,707       42       3,184,665        
Issuance of common stock in a business combination (in shares)         2,959,871                
Issuance of common stock in a business combination 2,219,903       30       2,219,873        
Cash paid in lieu of fractional shares in a business combination (in shares)         (41)                
Cash paid in lieu of fractional shares in a business combination (145)               (145)        
Issuance of common stock and warrants, net of issuance costs (in shares)         16,928,204                
Issuance of common stock and warrants, net of issuance costs 10,164,546       169       10,164,377        
Intrinsic value of beneficial conversion feature associated convertible debt 257,973               257,973        
Issuance of common stock upon the cashless exercise of warrants and reclassification of derivative liability to additional paid-in-capital (in shares)         18,153                
Issuance of common stock upon the cashless exercise of warrants and reclassification of derivative liability to additional paid-in-capital 48,339               48,339        
Stock-based compensation 907,460               907,460        
Net loss (7,435,422)                       (7,435,422)
ENDING BALANCE at Dec. 31, 2011 $ 9,481,123       $ 369       $ 40,961,180       $ (31,480,426)
ENDING BALANCE (in shares) at Dec. 31, 2011         36,907,824